SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1551Journal of Clinical Oncology, Vol 22, No 22 (November 15), 2004: pp. 4632-4642 zeta1961-12/6/2004
1550Ward, <<No Miljenko, they don't mess around, they KNOW what they are Miljenko Zuanic-12/6/2004
1549Lol, Ward, you have a long memory!tom pope-12/6/2004
1548I will, once again, bet on the MGI management team and their recent acquisitionsWard Knutson-12/6/2004
1547I haven't had time to let it sink in yet and I only heard half of the presenIcebrg-12/6/2004
1546Dacogen -Decitabine- for Injection Data Presented at American Society of HematolIcebrg-12/6/2004
1545I guess this downgrade has mostly to do with the medicare ruling on infusion prikenhott-11/19/2004
1544MGI Pharma initiated with "hold" Thursday, November 18, 2004 9:01:10 Icebrg-11/19/2004
1543MGI Pharma initiated with "outperform" Friday, November 05, 2004 1:21Icebrg-11/6/2004
1542SuperGen and MGI PHARMA Announce Submission of Dacogen NDA to U.S. FDA Monday Nosim1-11/1/2004
1541Thanks, Erik. Had no idea that Vernalis had any connection here, but on a littlnigel bates-10/29/2004
1540Decreased expression of DNMT1 at the mRNA level following 7 day infusion of the Icebrg-10/27/2004
1539SuperGen and MGI PHARMA Announce Acceptance of Dacogen MAA for Review by EMEA MoA.J. Mullen-10/25/2004
1538Jason Zhang should add Aloxi (PONV) to his summary. IMOseminole-10/22/2004
1537MGI Pharma initiated with "neutral weight" - update Thursday, OctoberIcebrg-10/22/2004
1536From today's earning's release: </i>For the year ending December Biomaven-10/13/2004
1535MethylGene/MGI Pharma The status of the cooperation agreement regarding MG98 beIcebrg-10/11/2004
1534MethylGene Initiates MG98 Phase II Trial In Metastatic Renal Cell Cancer WednesdIcebrg-10/11/2004
1533Cell Cycle Effects and Induction of Premitotic Apoptosis by Irofulven in SynchroIcebrg-10/7/2004
1532Aesgen - From 8-K filed yesterday. Item 2.01 Completion of Acquisition or DispoIcebrg-10/2/2004
1531From Briefing. It's all I could find, no other fuller article <I>12:5tom pope-9/27/2004
1530MGI PHARMA and SuperGen Announce Closing of Stock Purchase Agreement and EffectiIcebrg-9/22/2004
1529He is just getting a little press before MGI presents at BoA and Merrill meetingseminole-9/20/2004
1528MGI Pharma "outperform" [The guys at Robert Baird have a habit of sayIcebrg-9/20/2004
1527Item 2.01 Completion of Acquisition or Disposition of Assets [From today's Icebrg-9/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News